Timothy Walsh, Cardiff University
CANCELLED Friday, 2 December 2016 at 14:00 in the Chadwick amphitheatre, EMBL Grenoble
Timothy Walsh, Cardiff University
Global antimicrobial resistance: When two worlds collide
Abstract
Will be updated.
Biography
Timothy Walsh is currently Professor of Medical Microbiology and Antibiotic Resistance at Cardiff University, Cardiff, Wales, and leads an active research in antibiotic resistance. Previously, he was a Reader in Medical Microbiology at the University of Bristol following several postdoctoral research positions in London, UK. Prof. Walsh is a member of the Australian Society of Microbiology, Society for General Microbiology (UK), British Society of Antimicrobial Chemotherapy, American Society of Microbiology and European Society of Clinical Microbiology and Infectious Diseases. Prof. Walsh’s research is focused on unusual mechanisms of antimicrobial resistance and how they are mobilised into the clinical sector and spread once established. He is also interested in assessing the burden of AMR in low-middle income countries, particularly vulnerable populations. He has published/presented over 400 papers in particular on the characterisation of β-lactamases within Gram-negative bacteria, in journals such as Clinical Microbiological Reviews, Microbiology and Molecular Biology Reviews, Journal of Clinical Microbiology, Nature Lancet and Lancet Infectious Diseases. His research has been funded by the, EC, Wellcome Trust, European Union, British Society of Antimicrobial Chemotherapy, BBSRC, and the Gates Foundation. After obtaining a BSc in Applied Laboratory Science and a Post Graduate Diploma of Immunology/Microbiology at the University of Tasmania in Australia, Prof. Walsh earned his PhD in Molecular Microbiology at the University of Bristol. He is in the process of obtaining his MRCPath (London) and DSc (Australia). He currently hold an honorary chair at Murdoch University, Australia is director of BARNARDS and holds several advisory positions including Chinese CDC and CAU, ECDC, WHO, BIRDY (Children's Antibiotic Resistant infections in Low-Income countries: an international cohort study) and Médecins Sans Frontières. He has also conducted numerous media interviews on AMR.